testing for esr1 mutations to guide therapy for hr-positive, her2-negative metastatic breast canc...
Published 5 months ago • 31 plays • Length 10:42Download video MP4
Download video MP3
Similar videos
-
14:09
endocrine and targeted therapy for hr-positive, her2-negative metastatic breast cancer – capivase...
-
20:05
esr1 mutation: the need for & role of testing in er / her2- advanced or metastatic breast cancer
-
37:03
esr1 mutations in metastatic breast cancer: should i get tested?
-
1:02:29
understanding progression: how to identify and treat esr1 mutations in hr mbc
-
4:48
breast cancer breakthroughs: the importance of esr1 mutations in metastatic breast cancer
-
2:32
dr. goetz on treatment challenges for esr1-mutant breast cancer
-
2:06
elaine 1: esr1 mutations in ctdna from er /her2- mbc treated with lasofoxifene or fulvestrant
-
1:12
dr. fuqua on esr1 mutations in primary breast cancer
-
42:02
asco breast cancer update | jane meisel, md | 2022 review and renew sedona
-
2:35
lasofoxifene shows promise for women with esr1-mutated mbc
-
1:26
dr. rugo on rationale for the elaine study in esr1-mutated er /her2- breast cancer
-
55:33
personalized medicine: the role of testing in metastatic breast cancer
-
1:10
destiny-04: her2 1 /fish- metastatic breast cancer tdxd treatment | jane meisel, md | asco22 updates
-
8:12
her2 testing in metastatic breast cancer
-
1:47
dr. goncalves describes research involving the esr1 mutation in breast cancer
-
13:15
metastatic hr breast cancer
-
7:23
utilizing molecular testing to guide treatment options in breast cancer
-
9:02
endocrine resistance in hr metastatic breast cancer
-
53:55
report back from asco on metastatic breast cancer